Excellent companion invited editorial from Stefano Partelli 🇮🇹 SURGERY Journal

Mesentery-sparing resection for small bowel #NETs : resectability is in the 👁️ of the beholder 👉🏻spare arterial branches, spare bowel length, make proximal tumors resectable, for benefit of patient outcomes & QoL 📸credit Ino De Martino

European Society of Surgical Oncology (ESSO) Advanced course on pancreatic cancer: thanks to Stefano Partelli for hosting us at Ospedale San Raffaele 💥 MDT-like discussions on #PDAC management 💥 pushing the limits EYSAC Elena Rangelova PD Dr. Felix Nickel The Roux Group YOUPPIE Pancreas Gabriele Capurso MD, PhD🇺🇦

Day 1⃣ of the #ESSO Advanced Course on #PancreaticCancer kicks off! 🌟 Experts are sharing their knowledge to advance #surgicaloncology. Let’s tackle pancreatic cancer together! 💪 #OncologyTraining EYSAC Elena Rangelova Stefano Partelli

European Society of Surgical Oncology (ESSO) EYSAC Elena Rangelova Stefano Partelli I'm thrilled to see experts coming together to tackle pancreatic cancer through surgical oncology. Let's indeed work together to advance treatments for this devastating disease.

Highway to disaster - complex PPPD case for #chronicPancreatitis discussed at European Society of Surgical Oncology (ESSO) course: 🐉drain - CT - drain - CT ? ⁉️ total pancreatectomy 🦷 think nutrition 🫂 IR colleague is best friend Stefano Partelli Giovanni Marchegiani Declan Mohamed Elmasry The Society of Radiologists in Training

Gabriele Capurso MD, PhD🇺🇦 sharing insight on GI dysfunction after pancreatic surgery European Society of Surgical Oncology (ESSO) course: enzymes & 🥪 & HCl at wrong ⏰️ at wrong place #asynchrony 👉 don't blame #oncologist 🤢 complex Sx 💊 simple solution #PERT #rifaximine #cholestyramine not asking pt = not knowing

Not all #NETs are equal - insights from #NETTER2 at #ESMO24 👉🏻 prognosis & response depend on 🔑 factors ✅Origin - small bowel > pancreas ✅Lower Ki67 ✅High SSTR uptake ❌NOT disease spread Full work-up & specialized assessment crucial to personalize treatment plans 🦓

🚨 #PRODIGE44 - preop radiation for LA-BR-PDAC Phase 2 of👥110 pts Preop mFOLFIRINOX + rads🆚no rads ❌No difference R0 ❌No difference OS or PFS #ESMO24 really hitting nail in⚰️of neoadj rads in GI cancers 🎉Great news: close 50 months median OS with resection after NAT!

Fantastic European Society of Surgical Oncology (ESSO) Pancreatic Cancer Advanced course in Milan last week. Thanks for invitation Stefano Partelli. Superb chairs & faculty Sven Mieog Stefano Crippa SAUVANET Alain Elena Rangelova PD Dr. Felix Nickel T.Hackert and esp great discussions with the participants! Don’t miss this 2025!

📣How can be slippery to give indications for surgery in patients with pancreatic NET… 😥 ‼️ 40% risk of inadequate treatment ✅ Tumor size is the only driver for decision-making We need reliable biomarkers for guiding surgeons 🔄 BJS Open Università Vita-Salute San Raffaele academic.oup.com/bjsopen/articl…

Absolutely agree with Stefano Partelli ! We need more research and trials to define other markers of agressiveness in the sporadic and syndromic setting

🔍Still looking for an effective preop therapy to downstage #PNETs PRRT is promising☢️👇🏻 Questions remaining🤨 1⃣Where do response rates from RCT happen? 2⃣Is response enough to move to resectability? 3⃣Patient selection? definitions of resectability needed for PNETs Thor Halfdanarson

Say it louder 🗣️!!!! Society of Surgical Oncology Society of Black Academic Surgeons

We're thrilled to welcome Dr. Callisia Clarke as our new Board Secretary! A leader in surgical oncology and personalized cancer care, Dr. Clarke will begin her role at our Annual Symposium in November. Congratulations! 👏 #NANETS #Oncology #CancerCare #Leadership

#NET model meeting ⁦National Cancer Institute⁩ with Anna Battistella⁩ from ⁦Stefano Partelli⁩’ group thank you for sharing your great #PNET model with my team ⁦Steven Forsythe⁩ ⁦Jim Madigan⁩, Srujana Yellapragada and new member Sunanda ⁦NCI Surgical Oncology⁩

The OncoAlert 🚨Coverage #ESSO43 DAY THREE Definition of high risk pNEN - surgical and biological perspective Speaker:  Dr. Stefano Partelli 🇮🇹 Stefano Partelli While the probability of cure after radical surgery for pancreatic neuroendocrine neoplasms (pNENs) is high, a subset of

Pleasure to co-chair pancreatic #neuroendocrine session with Stefan Stättner in beautiful #Darwin room in #Antwerp 🫂 many people staying till the very end of #ESSO43 Thanks to speakers Marianne Pavel Boris Deroose Stefano Partelli European Society of Surgical Oncology (ESSO) OncoAlert ENETS YOUPPIE Pancreas

🔑message worth repeating: can different than should Stefano Partelli at #ESSO43 Lots to learn to individualize risk assessment of pancreas #NETs, in the interim ▪️NET is not adenocarcinoma ▫️each one is different ▪️30% potentially overtreated ▫️6% potentially undertreated

Julie Hallet Stefano Partelli NANETS ENETS European Society of Surgical Oncology (ESSO) Society of Surgical Oncology Stefan Stättner Dana Sochorova Alexandra Gangi, MD Teodora Dumitra MD PhD FRCSC Great meeting you all and NETwork! 🤩😂 #ESSO43 Stefan Stättner Alexandra Gangi, MD Stefano Partelli Julie Hallet